[Skip to Content]

Upstate Active Clinical Trials

Study Title:

APAL2020SC: Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias

What is the purpose of the study? (in Layman's terms, please describe the study)

Developing New Therapies for Relapsed Leukemias

Upstate Institutional Review Board (IRB) Number:

1926413

Study/Protocol ID:

APAL2020SC

Study Phase:

N/A

Patient Age Group:

Children

Principal Investigator:

Melanie A Comito

Who is eligible?

Patients must be less than 22 years of age at the time of study enrollment.

What is involved if I participate?

  • How long is the study?
    TBD
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    blood draws, bone marrow biopsy/aspirate

Where will the study take place?

SUNY Upstate Medical University

Other Information:

N/A

Who can I contact for more information?

Name: Suzanne M Majewski
Phone: 315-464-7232
Email: [email protected]

Return to Previous Page || Search Again

Top